The objective of this study was to determine the antibiotic resistance amongst beta-haemolytic streptococci (BHS) from North India. A total of 155 BHS isolates, comprising group A streptococci (GAS) (102), group C streptococci (GCS) (25) and group G streptococci (GGS) (28), collected from patients with pharyngitis, rheumatic fever, skin disease and invasive disease were analysed for their antimicrobial susceptibility to 20 antibiotics using the Kirby–Bauer disc diffusion method. The MICs of penicillin, tetracycline, clarithromycin, azithromycin and erythromycin were also determined using the HiComb test, following the Clinical and Laboratory Standards Institute guidelines. The results showed that 37.4 % of BHS isolates were susceptible to all antibiotics and 19.4 % were highly resistant to tetracycline; however, only 2.6–5.2 % were resistant to macrolides. The tetracycline resistance (P<0.05) of BHS was found to be statistically significant. GAS isolates from different sources of infection also showed statistically significant antibiotic resistance to azithromycin (P = 0.029). Multi-drug resistance was found irrespective of streptococcal emm types. No association between GAS emm types and drug resistance was seen. MIC determination showed all isolates to be susceptible to the five antibiotics tested, except for two GAS and one GGS isolates that were resistant to clarithromycin, and one GAS skin isolate that was resistant to tetracycline. This study suggests that the variation in antibiotic resistance amongst BHS isolates from North India is independent of the isolation source and emm type distribution, hence emphasizing the need for a longitudinal surveillance in different regions of India.
AggarwalP.,
IchhpujaniR. L.,
Rai ChowdhuriA. N.1984; Antibiotic sensitivity of beta-haemolytic streptococci – a four year rural and urban survey report. J Commun Dis 16:131–135[PubMed]
BharathiR. S.,
SharmaV.,
SoodR.,
ChakladarA.,
SinghP.,
RamanD. K.2009; Management of necrotizing myositis in a field hospital: a case report. Scand J Trauma Resusc Emerg Med 17:20 [View Article][PubMed]
BrahmadathanK. N.,
AnithaP.,
GladstoneP.2005; Increasing erythromycin resistance among group A streptococci causing tonsillitis in a tertiary care hospital in southern India. Clin Microbiol Infect 11:335–337 [View Article][PubMed]
CapoorM. R.,
NairD.,
DebM.,
BatraK.,
AggarwalP.2006; Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India. Jpn J Infect Dis 59:334–336[PubMed]
CLSI2012; Performance Standards for Antimicrobial Disk Susceptibility Testing; 22nd Information Supplement, M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute;
DhakalR.,
SujathaS.,
ParijaS. C.,
BhatB. V.2010; Asymptomatic colonization of upper respiratory tract by potential bacterial pathogens. Indian J Pediatr 77:775–778 [View Article][PubMed]
ErdemG.,
FordJ.,
JohnsonD.,
AbeL.,
YamagaK.,
KaplanE.2005; Erythromycin-resistant group A streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types. J Clin Microbiol 43:2497–2499 [View Article][PubMed]
HsuehP. R.,
ShyrJ. M.,
WuJ. J.2005; Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 40:903–905 [View Article][PubMed]
Hull VanceS.,
TucciM.,
BenghuzziH.2011; Evaluation of the antimicrobial efficacy of green tea extract (egcg) against streptococcus pyogenesin vitro – biomed 2011. Biomed Sci Instrum 47:177–182[PubMed]
InoueM.,
FarrellD. J.,
KanekoK.,
AkizawaK.,
FujitaS.,
KakuM.,
IgariJ.,
YamaguchiK.,
YamanakaK.other authors2008; Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1–5 (1999–2004). Microb Drug Resist 14:109–117 [View Article][PubMed]
JainA.,
ShuklaV. K.,
TiwariV.,
KumarR.2008; Antibiotic resistance pattern of group-A beta-hemolytic streptococci isolated from North Indian children. Indian J Med Sci 62:392–396 [View Article][PubMed]
KatajaJ.,
HuovinenP.,
MuotialaA.,
Vuopio-VarkilaJ.,
EfstratiouA.,
HallasG.,
SeppäläH.Finnish Study Group for Antimicrobial Resistance1998; Clonal spread of group A streptococcus with the new type of erythromycin resistance. J Infect Dis 177:786–789 [View Article][PubMed]
KittangB. R.,
BruunT.,
LangelandN.,
MylvaganamH.,
GlambekM.,
SkredeS.2011; Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin Microbiol Infect 17:358–364 [View Article][PubMed]
KohE. H.,
KimS.,
LeeN. Y.2008; Decrease of erythromycin resistance in group A streptococci by change of emm distribution. Jpn J Infect Dis 61:261–263[PubMed]
LindbaekM.,
HøibyE. A.,
LermarkG.,
SteinsholtI. M.,
HjortdahlP.2005; Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A. Br J Gen Pract 55:615–619[PubMed]
MacrisM. H.,
HartmanN.,
MurrayB.,
KleinR. F.,
RobertsR. B.,
KaplanE. L.,
HornD.,
ZabriskieJ. B.1998; Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J 17:377–381 [View Article][PubMed]
MathurP.,
KapilA.,
DasB.,
DhawanB.,
DwivediS. N.2002; Invasive beta-haemolytic streptococcal infections in a tertiary care hospital in northern India. J Med Microbiol 51:791–792[PubMed]
MetzgarD.,
McDonoughE. A.,
HansenC. J.,
BlaesingC. R.,
BaynesD.,
HawksworthA. W.,
BlairP. J.,
FaixD. J.,
RussellK. L.2010; Local changes in rates of group A streptococcus disease and antibiotic resistance are associated with geographically widespread strain turnover events. Virulence 1:247–253 [View Article][PubMed]
NortonR.,
SmithH.V.,
WoodN.,
SiegbrechtE.,
RossA.,
KetheesanN.2004; Invasive group A streptococcal disease in North Queensland (1996–2001). Indian J Med Res 119 S:148–151
OliverM. A.,
García-ReyC.,
BoschR.,
AlbertíS.2007; Evaluation of the ability of erythromycin-resistant and -susceptible pharyngeal group A streptococcus isolates from Spain to enter and persist in human keratinocytes. J Med Microbiol 56:1485–1489 [View Article][PubMed]
PfallerM.A.,
JonesR.N.Microbiology Resource Committee, College of American Pathologists2006; Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists microbiology surveys program (2001–2003). Arch Pathol Lab Med 130:767–778
RayD.,
SinhaS.,
SahaS.,
KarmakarS.,
DuttaR. N.,
BhattacharyaS.,
PalN. K.,
BhattacharyaB.2010; A preliminary sentinel surveillance report on antibiotic resistance trend of Streptococcus pyogenes in Kolkata region, India. Am J Med Sci 3:146–151
RijalK. R.,
DhakalN.,
ShahR. C.,
TimilsinaS.,
MahatoP.,
ThapaS.,
GhimireP.2009; Antibiotic susceptibility of group A streptococcus isolated from throat swab culture of school children in Pokhara, Nepal. Nepal Med Coll J 11:238–240[PubMed]
RoweR. A.,
StephensonR. M.,
EastD. L.,
WrightS.2009; Mechanisms of resistance for Streptococcus pyogenes in northern Utah. Clin Lab Sci 22:39–44[PubMed]
SaviniV.,
CatavitelloC.,
TaliaM.,
MannaA.,
PompettiF.,
Di BonaventuraG.,
Di GiuseppeN.,
FebboF.,
BalbinotA.other authors2008; β-lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis pharyngitis patients. J Clin Microbiol 46:814–816 [View Article][PubMed]
SmeestersP. R.,
CadarS.,
DrèzeP. A.,
CamposD.,
Van MelderenL.2010; Polyclonal dissemination of tetracycline resistance among Streptococcus pyogenes paediatric isolates from Brazil. J Infect Dev Ctries 4:704–711 [View Article][PubMed]
TraubW. H.,
LeonhardB.1997; Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43:10–20 [View Article][PubMed]
ZaoutisT.,
SchneiderB.,
Steele MooreL.,
KleinJ. D.1999; Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes. J Clin Microbiol 37:3380–3383[PubMed]